News

Tempus Press Release CHICAGO -- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tempus...

Single-use device reprocessing is poised to drive significant cost savings in coronary and peripheral procedures conducted in ambulatory surgery centers and office-based labs.

ALBUQUERQUE, N.M. -- Today Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (Nasdaq: GEHC) announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System...

AliveCor, the global leader in AI-powered cardiology, today announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of KAI™ 12L AI technology and the Kardia™ 12L ECG System. This is the world’s first AI that can...

BaroPace Inc. announces its Phase I first-in-human trial of PressurePaceTM.

The upsized VASCADE MVP XL system utilizes 58% more collagen and a larger disc than the current VASCADE MVP system, providing a robust closure solution for procedures requiring 10-12F sheaths (up to 15F in outer diameter) such as cryoablation...

SILVER SPRING, Md., June 17, 2024 — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during...

Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical procedures Automated workflows contribute to greater flexibility and...

Company Committed to TEECAD for Use with Smaller Transesophageal Echocardiography (TEE) Probes

Collaboration aims to accelerate speed to diagnosis and treatment of hypertrophic cardiomyopathy